Rational drug design

Search documents
Esperion to Report Second Quarter 2025 Financial Results on August 5
Globenewswire· 2025-07-22 12:00
A live audio webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company's website for approximately 90 days. Investors: Alina Venezia investorrelations@esperion.com (734) 887-3903 Esperion Therapeutics Media: Tiffany Aldrich corporateteam@esperion.com (616) 443-8438 ANN ARBOR, Mich., July 22, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today ann ...
Esperion Appoints Robert E. Hoffman to Board of Directors
Globenewswire· 2025-04-01 12:00
- Veteran Industry Executive Brings Decades of Financial and Leadership Experience - ANN ARBOR, Mich., April 01, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the appointment of Robert E. Hoffman as an independent director, effective immediately, and he will also serve as Chairperson of the Audit Committee effective May 29, 2025. In addition, the Company announced that Nicole Vitullo and Antonio M. Gotto, Jr., M.D., D. Phil. will step down from the board of directors, effective June 1, 20 ...